BSP Pharmaceuticals S.p.A. is proud to participate at the next 7th Annual High Potent Medicines Conference of London organized by MARKETSandMARKETES.
The conference will focus on case studies related to development, rapid scaling, validation, and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product. This event will share the latest industry trends, advancements and future growth in the highly potent medicines market where leading industry experts will discuss the strategies for both pharma and CMO’s by presenting expert keynote presentations, live case studies and breakthrough panel sessions.
Save the Date!!! Next Wednesday, 25th of May, our EHS & Toxicology Director, Fabio Zenobi, will present its speech 'Manufacturing of oncological products by a CDMO' during the Day1into the Session 1 – Process Development and Scale up, from 12:35 (BST)